Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 11/2012

01-11-2012 | Article

Volatile organic compound analysis by ion molecule reaction mass spectrometry for Gram-positive bacteria differentiation

Authors: M. E. Dolch, C. Hornuss, C. Klocke, S. Praun, J. Villinger, W. Denzer, G. Schelling, S. Schubert

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 11/2012

Login to get access

Abstract

Approximately 50 % of all clinically proven infections in critically ill patients are caused by Gram-positive bacteria. The timely and appropriate treatment of these infections is vital in order to avoid negative outcomes. Hence, fast and reliable methods are needed for the early detection and identification of microorganisms. Recently, direct mass spectrometry-based analysis of volatile organic compounds emitted by microorganisms has been employed to study Gram-negative bacteria. Here, we report a feasibility study of ion molecule reaction mass spectrometry (IMR-MS) for in vitro growth detection and species differentiation of selected Gram-positive bacteria that are frequently isolated in blood culture samples, namely, Enterococcus faecalis, Enterococcus faecium, Staphylococcus aureus, and Staphylococcus epidermidis. Ion molecule reaction mass spectrometry was used to analyze the headspace above cultures containing Gram-positive bacteria incubated at 37 °C starting with 102 colony-forming units (CFU)/ml. Measurements to determine the presence of volatile organic compounds were performed 4, 8, and 24 h after incubation, respectively. The detection of microbial growth was accomplished already after 8 h in cultures containing E. faecalis. After 24 h of incubation, characteristic mass spectra were obtained for all species. Processing these mass spectra by hierarchic clustering and principal component analysis (PCA) enabled us to differentiate between bacterial species. IMR‐MS in conjunction with a cumulative end-point model provides the means for rapid growth detection and differentiation of Gram-positive bacteria on the species level, typically within an analysis time of less than 3 min per sample.
Literature
1.
go back to reference Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29(7):1303–1310PubMedCrossRef Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29(7):1303–1310PubMedCrossRef
2.
go back to reference Brun-Buisson C, Meshaka P, Pinton P, Vallet B; EPISEPSIS Study Group (2004) EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 30(4):580–588PubMedCrossRef Brun-Buisson C, Meshaka P, Pinton P, Vallet B; EPISEPSIS Study Group (2004) EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 30(4):580–588PubMedCrossRef
3.
go back to reference Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, Mayer K, Oppert M, Olthoff D, Quintel M, Ragaller M, Rossaint R, Stuber F, Weiler N, Welte T, Bogatsch H, Hartog C, Loeffler M, Reinhart K (2007) Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 33(4):606–618PubMedCrossRef Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, Mayer K, Oppert M, Olthoff D, Quintel M, Ragaller M, Rossaint R, Stuber F, Weiler N, Welte T, Bogatsch H, Hartog C, Loeffler M, Reinhart K (2007) Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 33(4):606–618PubMedCrossRef
4.
go back to reference Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348(16):1546–1554PubMedCrossRef Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348(16):1546–1554PubMedCrossRef
5.
go back to reference Retamar P, Portillo MM, López-Prieto MD, Rodríguez-López F, de Cueto M, García MV, Gómez MJ, Del Arco A, Muñoz A, Sánchez-Porto A, Torres-Tortosa M, Martín-Aspas A, Arroyo A, García-Figueras C, Acosta F, Corzo JE, León-Ruiz L, Escobar-Lara T, Rodríguez-Baño J; SAEI/SAMPAC Bacteremia Group (2012) Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis. Antimicrob Agents Chemother 56(1):472–478PubMedCrossRef Retamar P, Portillo MM, López-Prieto MD, Rodríguez-López F, de Cueto M, García MV, Gómez MJ, Del Arco A, Muñoz A, Sánchez-Porto A, Torres-Tortosa M, Martín-Aspas A, Arroyo A, García-Figueras C, Acosta F, Corzo JE, León-Ruiz L, Escobar-Lara T, Rodríguez-Baño J; SAEI/SAMPAC Bacteremia Group (2012) Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis. Antimicrob Agents Chemother 56(1):472–478PubMedCrossRef
6.
go back to reference Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, Dodek P, Wood G, Kumar A, Simon D, Peters C, Ahsan M, Chateau D; Cooperative Antimicrobial Therapy of Septic Shock Database Research Group (2009) Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136(5):1237–1248PubMedCrossRef Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, Dodek P, Wood G, Kumar A, Simon D, Peters C, Ahsan M, Chateau D; Cooperative Antimicrobial Therapy of Septic Shock Database Research Group (2009) Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136(5):1237–1248PubMedCrossRef
7.
go back to reference Bassetti M, Ginocchio F, Giacobbe DR (2011) New approaches for empiric therapy in Gram-positive sepsis. Minerva Anestesiol 77(8):821–827PubMed Bassetti M, Ginocchio F, Giacobbe DR (2011) New approaches for empiric therapy in Gram-positive sepsis. Minerva Anestesiol 77(8):821–827PubMed
8.
go back to reference Schulz S, Dickschat JS (2007) Bacterial volatiles: the smell of small organisms. Nat Prod Rep 24(4):814–842PubMedCrossRef Schulz S, Dickschat JS (2007) Bacterial volatiles: the smell of small organisms. Nat Prod Rep 24(4):814–842PubMedCrossRef
9.
go back to reference Mann S (1966) Über den Geruchsstoff von Pseudomonas aeruginosa. Arch Mikrobiol 54(2):184–190CrossRef Mann S (1966) Über den Geruchsstoff von Pseudomonas aeruginosa. Arch Mikrobiol 54(2):184–190CrossRef
10.
go back to reference Cox CD, Parker J (1979) Use of 2-aminoacetophenone production in identification of Pseudomonas aeruginosa. J Clin Microbiol 9(4):479–484PubMed Cox CD, Parker J (1979) Use of 2-aminoacetophenone production in identification of Pseudomonas aeruginosa. J Clin Microbiol 9(4):479–484PubMed
11.
go back to reference Labows JN, McGinley KJ, Webster GF, Leyden JJ (1980) Headspace analysis of volatile metabolites of Pseudomonas aeruginosa and related species by gas chromatography–mass spectrometry. J Clin Microbiol 12(4):521–526PubMed Labows JN, McGinley KJ, Webster GF, Leyden JJ (1980) Headspace analysis of volatile metabolites of Pseudomonas aeruginosa and related species by gas chromatography–mass spectrometry. J Clin Microbiol 12(4):521–526PubMed
12.
go back to reference Julák J, Stránská E, Procházková-Francisci E, Rosová V (2000) Blood cultures evaluation by gas chromatography of volatile fatty acids. Med Sci Monit 6(3):605–610PubMed Julák J, Stránská E, Procházková-Francisci E, Rosová V (2000) Blood cultures evaluation by gas chromatography of volatile fatty acids. Med Sci Monit 6(3):605–610PubMed
13.
go back to reference Probert CS, Jones PR, Ratcliffe NM (2004) A novel method for rapidly diagnosing the causes of diarrhoea. Gut 53(1):58–61PubMedCrossRef Probert CS, Jones PR, Ratcliffe NM (2004) A novel method for rapidly diagnosing the causes of diarrhoea. Gut 53(1):58–61PubMedCrossRef
14.
go back to reference Allardyce RA, Langford VS, Hill AL, Murdoch DR (2006) Detection of volatile metabolites produced by bacterial growth in blood culture media by selected ion flow tube mass spectrometry (SIFT-MS). J Microbiol Methods 65(2):361–365PubMedCrossRef Allardyce RA, Langford VS, Hill AL, Murdoch DR (2006) Detection of volatile metabolites produced by bacterial growth in blood culture media by selected ion flow tube mass spectrometry (SIFT-MS). J Microbiol Methods 65(2):361–365PubMedCrossRef
15.
go back to reference Bunge M, Araghipour N, Mikoviny T, Dunkl J, Schnitzhofer R, Hansel A, Schinner F, Wisthaler A, Margesin R, Märk TD (2008) On-line monitoring of microbial volatile metabolites by proton transfer reaction-mass spectrometry. Appl Environ Microbiol 74(7):2179–2186PubMedCrossRef Bunge M, Araghipour N, Mikoviny T, Dunkl J, Schnitzhofer R, Hansel A, Schinner F, Wisthaler A, Margesin R, Märk TD (2008) On-line monitoring of microbial volatile metabolites by proton transfer reaction-mass spectrometry. Appl Environ Microbiol 74(7):2179–2186PubMedCrossRef
16.
go back to reference Chippendale TW, Španěl P, Smith D (2011) Time-resolved selected ion flow tube mass spectrometric quantification of the volatile compounds generated by E. coli JM109 cultured in two different media. Rapid Commun Mass Spectrom 25(15):2163–2172PubMedCrossRef Chippendale TW, Španěl P, Smith D (2011) Time-resolved selected ion flow tube mass spectrometric quantification of the volatile compounds generated by E. coli JM109 cultured in two different media. Rapid Commun Mass Spectrom 25(15):2163–2172PubMedCrossRef
17.
go back to reference O’Hara M, Mayhew CA (2009) A preliminary comparison of volatile organic compounds in the headspace of cultures of Staphylococcus aureus grown in nutrient, dextrose and brain heart bovine broths measured using a proton transfer reaction mass spectrometer. J Breath Res 3(2):027001PubMedCrossRef O’Hara M, Mayhew CA (2009) A preliminary comparison of volatile organic compounds in the headspace of cultures of Staphylococcus aureus grown in nutrient, dextrose and brain heart bovine broths measured using a proton transfer reaction mass spectrometer. J Breath Res 3(2):027001PubMedCrossRef
18.
go back to reference Thorn RM, Reynolds DM, Greenman J (2011) Multivariate analysis of bacterial volatile compound profiles for discrimination between selected species and strains in vitro. J Microbiol Methods 84(2):258–264PubMedCrossRef Thorn RM, Reynolds DM, Greenman J (2011) Multivariate analysis of bacterial volatile compound profiles for discrimination between selected species and strains in vitro. J Microbiol Methods 84(2):258–264PubMedCrossRef
19.
go back to reference Zhu J, Bean HD, Kuo YM, Hill JE (2010) Fast detection of volatile organic compounds from bacterial cultures by secondary electrospray ionization-mass spectrometry. J Clin Microbiol 48(12):4426–4431PubMedCrossRef Zhu J, Bean HD, Kuo YM, Hill JE (2010) Fast detection of volatile organic compounds from bacterial cultures by secondary electrospray ionization-mass spectrometry. J Clin Microbiol 48(12):4426–4431PubMedCrossRef
20.
go back to reference Critchley A, Elliott TS, Harrison G, Mayhew CA, Thompson JM, Worthington T (2004) The proton transfer reaction mass spectrometer and its use in medical science: applications to drug assays and the monitoring of bacteria. Int J Mass Spectrom 239(2–3):235–241 Critchley A, Elliott TS, Harrison G, Mayhew CA, Thompson JM, Worthington T (2004) The proton transfer reaction mass spectrometer and its use in medical science: applications to drug assays and the monitoring of bacteria. Int J Mass Spectrom 239(2–3):235–241
21.
go back to reference Dolch ME, Frey L, Hornuss C, Schmoelz M, Praun S, Villinger J, Schelling G (2008) Molecular breath-gas analysis by online mass spectrometry in mechanically ventilated patients: a new software-based method of CO2-controlled alveolar gas monitoring. J Breath Res 2(3):037010PubMedCrossRef Dolch ME, Frey L, Hornuss C, Schmoelz M, Praun S, Villinger J, Schelling G (2008) Molecular breath-gas analysis by online mass spectrometry in mechanically ventilated patients: a new software-based method of CO2-controlled alveolar gas monitoring. J Breath Res 2(3):037010PubMedCrossRef
22.
go back to reference Hornuss C, Praun S, Villinger J, Dornauer A, Moehnle P, Dolch M, Weninger E, Chouker A, Feil C, Briegel J, Thiel M, Schelling G (2007) Real-time monitoring of propofol in expired air in humans undergoing total intravenous anesthesia. Anesthesiology 106(4):665–674PubMedCrossRef Hornuss C, Praun S, Villinger J, Dornauer A, Moehnle P, Dolch M, Weninger E, Chouker A, Feil C, Briegel J, Thiel M, Schelling G (2007) Real-time monitoring of propofol in expired air in humans undergoing total intravenous anesthesia. Anesthesiology 106(4):665–674PubMedCrossRef
23.
go back to reference Netzer M, Millonig G, Osl M, Pfeifer B, Praun S, Villinger J, Vogel W, Baumgartner C (2009) A new ensemble-based algorithm for identifying breath gas marker candidates in liver disease using ion molecule reaction mass spectrometry. Bioinformatics 25(7):941–947PubMedCrossRef Netzer M, Millonig G, Osl M, Pfeifer B, Praun S, Villinger J, Vogel W, Baumgartner C (2009) A new ensemble-based algorithm for identifying breath gas marker candidates in liver disease using ion molecule reaction mass spectrometry. Bioinformatics 25(7):941–947PubMedCrossRef
24.
25.
go back to reference Bruins M, Bos A, Petit PL, Eadie K, Rog A, Bos R, van Ramshorst GH, van Belkum A (2009) Device-independent, real-time identification of bacterial pathogens with a metal oxide-based olfactory sensor. Eur J Clin Microbiol Infect Dis 28(7):775–780PubMedCrossRef Bruins M, Bos A, Petit PL, Eadie K, Rog A, Bos R, van Ramshorst GH, van Belkum A (2009) Device-independent, real-time identification of bacterial pathogens with a metal oxide-based olfactory sensor. Eur J Clin Microbiol Infect Dis 28(7):775–780PubMedCrossRef
26.
go back to reference Scotter JM, Allardyce RA, Langford VS, Hill A, Murdoch DR (2006) The rapid evaluation of bacterial growth in blood cultures by selected ion flow tube-mass spectrometry (SIFT-MS) and comparison with the BacT/ALERT automated blood culture system. J Microbiol Methods 65(3):628–631PubMedCrossRef Scotter JM, Allardyce RA, Langford VS, Hill A, Murdoch DR (2006) The rapid evaluation of bacterial growth in blood cultures by selected ion flow tube-mass spectrometry (SIFT-MS) and comparison with the BacT/ALERT automated blood culture system. J Microbiol Methods 65(3):628–631PubMedCrossRef
27.
go back to reference Schulz S, Fuhlendorff J, Reichenbach H (2004) Identification and synthesis of volatiles released by the myxobacterium Chondromyces crocatus. Tetrahedron 60(17):3863–3872CrossRef Schulz S, Fuhlendorff J, Reichenbach H (2004) Identification and synthesis of volatiles released by the myxobacterium Chondromyces crocatus. Tetrahedron 60(17):3863–3872CrossRef
28.
go back to reference Amann A, Spanĕl P, Smith D (2007) Breath analysis: the approach towards clinical applications. Mini Rev Med Chem 7(2):115–129PubMedCrossRef Amann A, Spanĕl P, Smith D (2007) Breath analysis: the approach towards clinical applications. Mini Rev Med Chem 7(2):115–129PubMedCrossRef
Metadata
Title
Volatile organic compound analysis by ion molecule reaction mass spectrometry for Gram-positive bacteria differentiation
Authors
M. E. Dolch
C. Hornuss
C. Klocke
S. Praun
J. Villinger
W. Denzer
G. Schelling
S. Schubert
Publication date
01-11-2012
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 11/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1654-2

Other articles of this Issue 11/2012

European Journal of Clinical Microbiology & Infectious Diseases 11/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.